← Back to Clinical Trials
Recruiting NCT07123025

NCT07123025 Outcome of Partial Pulpotomy in Moderate and Severe Pulpitis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07123025
Status Recruiting
Phase
Sponsor Postgraduate Institute of Dental Sciences Rohtak
Condition Moderate Pulpitis
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2025-04-18
Primary Completion 2026-04-18

Eligibility & Interventions

Sex All sexes
Min Age 15 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
Partial Pulpotomy in Moderate PulpitisPartial Pulpotomy in Severe Pulpitis

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 120 participants in total. It began in 2025-04-18 with a primary completion date of 2026-04-18.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of the study is to compare the outcome of Partial Pulpotomy in mature permanent teeth with moderate and severe pulpitis. OBJECTIVE: Primary objective- to compare the difference in clinical and radiographic outcome of partial pulpotomy in mature permanent teeth with moderate and severe Pulpitis. Secondary objective- To evaluate and compare OHRQoL and postoperative pain after Partial Pulpotomy in teeth with Moderate Pulpitis and Severe Pulpitis. Subjects of age group 15 to 40 years will be included and divided into two groups 1. Permanent mature molars with Moderate Pulpitis 2. Permanent mature molars with Severe Pulpitis

Eligibility Criteria

Inclusion Criteria: 1. Patients aged 15-40 years. 2. Mature permanent mandibular molars with extremely deep caries on radiograph, giving positive response to pulp sensibility test. 3. For Moderate Pulpitis- strong, heightened and prolonged reaction to cold, which can last for minutes, possibly percussion sensitive and spontaneous dull pain that can be more or less suppressed with pain medication. For Severe Pulpitis- Severe spontaneous pain and clear pain reaction to warmth and cold stimuli, often, sharp to dull throbbing pain, patients have trouble sleeping because of the pain (gets worse when lying down). Tooth is very sensitive to touch and percussion. 4. Pulpal bleeding can be controlled within 10 minutes 5. Patients having normal periapical status with periapical index (PAI) score ≤ 2 6. Periodontally healthy teeth 7. Positive response to pulp sensibility test Exclusion Criteria: 1. Non restorable teeth 2. Negative response to vitality testing 3. Presence of sinus tract or soft tissue swelling 4. Absence of deep carious lesions radiographically 5. Radiographic signs of internal or external root resorption 6. Patient had moderate to severe pain, but preferred root canal treatment 7. Presence of sound dentin over pulp and pulp not exposed intraoperatively 8. Pulp haemorrhage could not be arrested within 10 minutes. 9. Necrotic pulp evident upon exposure 10. Pregnant women 11. Absence of antagonist teeth

Contact & Investigator

Central Contact

Dr. Pankaj Sangwan, MDS

✉ drps_1@yahoo.co.in

📞 9996112202

Principal Investigator

Dr. Pankaj Sangwan, MDS

PRINCIPAL INVESTIGATOR

PGIDS, Rohtak, Haryana 124001

Frequently Asked Questions

Who can join the NCT07123025 clinical trial?

This trial is open to participants of all sexes, aged 15 Years or older, up to 40 Years, studying Moderate Pulpitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07123025 currently recruiting?

Yes, NCT07123025 is actively recruiting participants. Contact the research team at drps_1@yahoo.co.in for enrollment information.

Where is the NCT07123025 trial being conducted?

This trial is being conducted at Rohtak, India.

Who is sponsoring the NCT07123025 clinical trial?

NCT07123025 is sponsored by Postgraduate Institute of Dental Sciences Rohtak. The principal investigator is Dr. Pankaj Sangwan, MDS at PGIDS, Rohtak, Haryana 124001. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology